NEXTGEN HEALTHCARE, INC (NXGN)
(Delayed Data from NSDQ)
$19.75 USD
+0.51 (2.65%)
Updated May 3, 2019 04:00 PM ET
After-Market: $19.76 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.75 USD
+0.51 (2.65%)
Updated May 3, 2019 04:00 PM ET
After-Market: $19.76 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
NextGen Virtual Visits Offers Remote Eye Care Facilities
by Zacks Equity Research
The offering will expand NextGen's (NXGN) ophthalmology services during the coronavirus crisis.
NextGen Virtual Visits Supports Women Health During COVID-19
by Zacks Equity Research
Capital Women's Care is set to expand NextGen's (NXGN) women's healthcare services during the coronavirus emergency.
Here's Why You Should Retain NextGen Healthcare Stock Now
by Zacks Equity Research
NextGen Healthcare (NXGN) continues to benefit from growing RCM and EHR markets, and solid recurring revenue base.
NextGen (NXGN) Earnings and Revenues Beat Estimates in Q4
by Zacks Equity Research
NextGen's (NXGN) fiscal fourth-quarter 2020 results gain from strong Recurring revenues.
Nextgen Healthcare (NXGN) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Nextgen Healthcare (NXGN) delivered earnings and revenue surprises of 5.26% and 0.41%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Retain NextGen Healthcare Stock Now
by Zacks Equity Research
NextGen Healthcare (NXGN) continues to benefit from growing RCM and EHR markets, and robust demand for other NextGen solutions.
NXGN or HMSY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NXGN vs. HMSY: Which Stock Is the Better Value Option?
Here's Why You Should Hold on to NextGen Healthcare Stock Now
by Zacks Equity Research
NextGen Healthcare (NXGN) continues to benefit from growing RCM and EHR markets, and robust demand for other NextGen solutions.
NextGen's New Platform Set to Improve Patient Engagement
by Zacks Equity Research
The availability of NextGen's (NXGN) Patient Experience Platform is likely to enable high-quality healthcare and drive patient engagement.
NextGen (NXGN) Earnings and Revenues Beat Estimates in Q3
by Zacks Equity Research
NextGen (NXGN) gains from Recurring revenues in Q3, bookings down.
Nextgen Healthcare (NXGN) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Nextgen Healthcare (NXGN) delivered earnings and revenue surprises of 15.00% and 1.85%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Nextgen Healthcare (NXGN) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Nextgen Healthcare (NXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NextGen Healthcare Boosts Patient Care With CHC Strategies
by Zacks Equity Research
NextGen Healthcare (NXGN) is likely to boost presence in health management with CHC Strategies delivering quality medical care through the company's Population Health platform.
Here's Why You Should Retain NextGen Healthcare for Now
by Zacks Equity Research
NextGen Healthcare (NXGN) is gaining traction from the U.S. RCM market and the growing EHR market. However, margin pressure remains a concern.
Nextgen Healthcare (NXGN) Up 2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Nextgen Healthcare (NXGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
San Gorgonio Hospital Picks Allscripts Sunrise Community Care
by Zacks Equity Research
Allscripts' (MDRX) Sunrise Community Care is an Azure-hosted platform offering clinical, financial and ambulatory content.
NextGen's Medfusion Buyout to Improve Patient Experience
by Zacks Equity Research
NextGen (NXGN) showcases new capabilities and services for its flagship NextGen Enterprise platform.
NextGen (NXGN) Q2 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
NextGen (NXGN) retains its fiscal 2020 revenue and EPS guidance.
Nextgen Healthcare (NXGN) Q2 Earnings Beat Estimates
by Zacks Equity Research
Nextgen Healthcare (NXGN) delivered earnings and revenue surprises of 4.35% and -0.09%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Nextgen Healthcare (NXGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Nextgen Healthcare (NXGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Hold on to NextGen Healthcare for Now
by Zacks Equity Research
NextGen Healthcare (NXGN) is gaining traction from the U.S. RCM market and the growing EHR market. However, margin pressure remains a concern.
SYNH vs. NXGN: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SYNH vs. NXGN: Which Stock Is the Better Value Option?
NextGen's (NXGN) Population Health Picked by Ohio-Based UH
by Zacks Equity Research
NextGen's (NXGN) EHR services are expected to enhance patient outcomes at UH.
Here's Why You Should Retain NextGen Healthcare Stock Now
by Zacks Equity Research
NextGen Healthcare (NXGN) is gaining traction from the U.S. RCM market and the growing EHR market. However, margin pressure remains a concern.
Bright Near-Term Outlook for Medical Info Systems Industry
by Sreyoshi Mukherjee
Growth prospects look bright for the Zacks Medical Info Systems industry, thanks to rising need for curtailing medical expenses and AI.